Literature DB >> 16869729

Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.

Etsuko Matsuzaki1, Fumi Takahashi-Yanaga, Yoshikazu Miwa, Masato Hirata, Yutaka Watanabe, Noriharu Sato, Sachio Morimoto, Takao Hirofuji, Katsumasa Maeda, Toshiyuki Sasaguri.   

Abstract

UNLABELLED: Because DIF-1 has been shown to affect Wnt/beta-catenin signaling pathway, the effects of DIF-1 on osteoblast-like cell lines, SaOS-2 and MC3T3-E1, were examined. We found that DIF-1 inhibited this pathway, resulting in the suppression of ALP promoter activity through the TCF/LEF binding site.
INTRODUCTION: Differentiation-inducing factor-1 (DIF-1), a morphogen of Dictyostelium, inhibits cell proliferation and induces cell differentiation in several mammalian cells. Previous studies showed that DIF-1 activated glycogen synthase kinase-3beta, suggesting that this chemical could affect the Wnt/beta-catenin signaling pathway. This pathway has been shown to be involved in bone biology.
MATERIALS AND METHODS: We studied the effects of DIF-1 on SaOS-2 and MC3T3-E1, osteosarcoma cell lines widely used as a model system for ostoblastic cells and murine osteoblast-like cell line, respectively. Reporter gene assays were also carried out to examine the effect of DIF-1 on the Wnt/beta-catenin signaling pathway.
RESULTS: DIF-1 inhibited SaOS-2 proliferation and reduced alkaline phosphatase (ALP) activity in a concentration- and a time-dependent manner. The expression of ALP was markedly suppressed by DIF-1-treatment in protein and mRNA levels. DIF-1 also suppressed the expression of other osteoblast differentiation markers, including core binding factor alpha1, type I collagen, and osteocalcin, in protein and mRNA levels and inhibited osteoblast-mediated mineralization. Subsequently, we examined the effect of DIF-1 on the Wnt/beta-catenin signaling pathway. We found that DIF-1 suppressed the expression of beta-catenin protein and the activity of the reporter gene containing T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) consensus binding sites. We examined the effect of DIF-1 on a reporter gene driven by the human ALP promoter and found that DIF-1 significantly reduced the ALP reporter gene activity through the TCF/LEF binding site (-1023/-1017 bp). Furthermore, the effect of DIF-1 on MC3T3-E1, a murine osteoblast-like cell line, was examined, and it was found that DIF-1 suppressed ALP mRNA expression by the reduction of the ALP reporter gene activity through the TCF/LEF binding site.
CONCLUSIONS: Our data suggest that DIF-1 inhibits Wnt/beta-catenin signaling, resulting in the suppression of ALP promoter activity. To our knowledge, this is the first report to analyze the role of the TCF/LEF binding site (-1023/-1017 bp) of the ALP gene promoter in osteoblast-like cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16869729     DOI: 10.1359/jbmr.060512

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts.

Authors:  Nahoko Eiraku; Norika Chiba; Toshiaki Nakamura; Muhammad Subhan Amir; Chang-Hwan Seong; Tomokazu Ohnishi; Joji Kusuyama; Kazuyuki Noguchi; Tetsuya Matsuguchi
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  Sphingosine-1-phosphate inhibits differentiation of C3H10T1/2 cells into adipocyte.

Authors:  Yoko Hashimoto; Etsuko Matsuzaki; Katsumasa Higashi; Fumi Takahashi-Yanaga; Aiko Takano; Masato Hirata; Fusanori Nishimura
Journal:  Mol Cell Biochem       Date:  2014-12-02       Impact factor: 3.396

3.  Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway.

Authors:  Ling Ling; Christian Dombrowski; Kin Mun Foong; Larisa M Haupt; Gary S Stein; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

4.  Lymphocyte enhancer-binding factor 1: an essential factor in odontoblastic differentiation of dental pulp cells enzymatically isolated from rat incisors.

Authors:  Satoshi Yokose; Takahiro Naka
Journal:  J Bone Miner Metab       Date:  2010-04-28       Impact factor: 2.626

5.  SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts.

Authors:  Elisabetta Lambertini; Tiziana Franceschetti; Elena Torreggiani; Letizia Penolazzi; Antonio Pastore; Stefano Pelucchi; Roberto Gambari; Roberta Piva
Journal:  BMC Mol Biol       Date:  2010-02-03       Impact factor: 2.946

6.  Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway.

Authors:  Tatsuya Yoshihara; Fumi Takahashi-Yanaga; Fumie Shiraishi; Sachio Morimoto; Yutaka Watanabe; Masato Hirata; Sumio Hoka; Toshiyuki Sasaguri
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

7.  Secreted frizzled related protein 1 is a target to improve fracture healing.

Authors:  Tripti Gaur; John J Wixted; Sadiq Hussain; Shannon L O'Connell; Elise F Morgan; David C Ayers; Barry S Komm; Peter V Bodine; Gary S Stein; Jane B Lian
Journal:  J Cell Physiol       Date:  2009-07       Impact factor: 6.384

8.  Wnt/β-catenin expression does not correlate with serum alkaline phosphatase concentration in canine osteosarcoma patients.

Authors:  Caroline M Piskun; Anantharaman Muthuswamy; Michael K Huelsmeyer; Victoria Thompson; Timothy J Stein
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

Review 9.  Dictyostelium: An Important Source of Structural and Functional Diversity in Drug Discovery.

Authors:  Yuzuru Kubohara; Haruhisa Kikuchi
Journal:  Cells       Date:  2018-12-21       Impact factor: 6.600

10.  ER stress regulates alkaline phosphatase gene expression in vascular smooth muscle cells via an ATF4-dependent mechanism.

Authors:  Malgorzata Furmanik; Catherine M Shanahan
Journal:  BMC Res Notes       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.